BIO-RAD LABORATORIES, INC. (BIO)

Import this data to Google Sheets with:

=jivedata("BIO","financials")

Full statements spill as a table. For one cell: =jivedata("BIO","Revenue") or =jivedata("BIO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

BIO-RAD LABORATORIES, INC.

BIO • CIK 0000012208

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Including Assessed Tax	$2,671,262	$2,566,500	$2,583,200	$2,583,200
Cost of Goods and Services Sold	$1,244,316	$1,187,600	$1,243,300	$1,245,500
Gross Profit	$1,426,946	$1,378,900	$1,339,900	$1,343,800
Selling, General and Administrative Expense	$841,723	$814,000	$844,300	$852,200
Research and Development Expense	$247,427	$295,900	$275,600	$265,700
Impairment of Intangible Assets (Excluding Goodwill)	—	—	$172,800	$172,800
Operating Income (Loss)	$337,796	$269,000	$47,200	$53,100
Interest Expense	$49,439	$48,900	$49,000	$48,800
Foreign Currency Transaction Gain (Loss), before Tax	$7,347	$3,900	$6,600	$7,600
Debt and Equity Securities, Unrealized Gain (Loss)	$-1,252,251	$-2,656,800	$900,400	$900,400
Other Nonoperating Income (Expense)	$106,443	$90,300	$90,300	$84,500
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-850,104	$-2,342,500	$995,500	$350,400
Income Tax Expense (Benefit)	$-212,780	$-498,300	$235,600	$128,000
Net Income (Loss) Attributable to Parent	$-637,324	$-1,844,200	$759,900	$222,400
Weighted Average Number of Shares Outstanding, Basic	29,209,000	28,214,000	27,263,000	26,534,000
Weighted Average Number of Shares Outstanding, Diluted	29,209,000	28,214,000	27,281,000	26,544,000
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements	0	0	18,000	10,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	212,000	226,000	336,000	219,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Property, Plant and Equipment, Net	$529,007	$528,100	$539,900	$539,900
Operating Lease, Right-of-Use Asset	$194,730	$160,500	$170,000	$154,000
Goodwill	$413,569	$410,500	$579,800	$574,300
Intangible Assets, Net (Excluding Goodwill)	$320,514	$293,600	$174,300	$160,000
Long-term Investments	$7,698,070	$4,839,200	$6,103,600	$5,723,600
Other Assets, Noncurrent	$94,850	$101,900	$102,700	$102,700
Assets	$12,299,070	$9,364,100	$10,576,500	$10,252,000
Long-term Debt, Excluding Current Maturities	$1,199,100	$1,200,400	$1,201,700	$803,000
Deferred Income Tax Liabilities, Net	$1,475,495	$818,000	$1,059,400	$982,200
Operating Lease, Liability, Noncurrent	$165,478	$131,400	$145,700	$133,100
Other Liabilities, Noncurrent	$195,113	$177,200	$199,100	$198,500
Liabilities	$3,557,937	$2,794,800	$3,122,900	$3,078,100
Cash and Cash Equivalents, at Carrying Value	$403,815	$488,100	$529,800	$517,000
Short-term Investments	$1,203,327	$1,176,400	$1,010,900	$1,101,500
Accounts Receivable, after Allowance for Credit Loss, Current	$489,017	$452,500	$460,600	$441,800
Inventory, Net	$780,517	$760,000	$740,700	$780,600
Prepaid Expense, Current	$140,040	$122,600	$136,500	$147,800
Other Assets, Current	$26,054	$30,700	$27,700	$31,800
Assets, Current	$3,048,330	$3,030,300	$2,906,200	$3,020,500
Accounts Payable, Current	$144,625	$122,300	$129,000	$143,500
Employee-related Liabilities, Current	$139,929	$124,200	$172,300	$150,500
Notes and Loans Payable, Current	$486	$1,200	$1,300	$400,700
Accrued Income Taxes, Current	$35,759	$31,200	$36,600	$36,600
Operating Lease, Liability, Current	$40,379	$41,700	$36,100	$33,600
Other Liabilities, Current	$161,621	$147,200	$141,700	$158,800
Liabilities, Current	$522,799	$467,800	$517,000	$961,300
Preferred Stock, Value, Issued	—	$0	$0	$0
Additional Paid in Capital	$449,075	$463,200	$476,000	$502,900
Treasury Stock, Value	$632,536	$772,100	$1,009,600	$1,009,600
Retained Earnings (Accumulated Deficit)	$9,260,629	$7,416,400	$8,176,300	$8,020,600
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-336,038	$-538,200	$-189,100	$-271,300
Stockholders' Equity Attributable to Parent	$8,741,133	$6,569,300	$7,453,600	$7,173,900
Accounts Receivable, Allowance for Credit Loss	$14,926	$9,200	$5,500	$4,700
Treasury Stock, Common, Shares	1,747,438	2,254,728	3,275,476	3,275,476
Preferred Stock, Shares Authorized	—	7,500,000	7,500,000	7,500,000
Preferred Stock, Shares Outstanding	—	0	0	0

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Proceeds from Customers	$2,684,248	$2,553,100	$2,656,400	$2,594,200
Payments to Suppliers and Employees	$2,240,486	$2,058,200	$2,058,900	$2,119,600
Interest Paid, Including Capitalized Interest, Operating and Investing Activities	$47,489	$46,500	$46,600	$46,600
Income Taxes Paid, Net	$129,593	$99,400	$61,600	$29,800
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$321	$9,200	$-16,900	$-16,900
Proceeds from Other Operating Activities	$100,101	$86,100	$81,000	$81,100
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-30,175	$85,400	$42,400	$147,100
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$404,369	$489,800	$532,200	$518,100
Net Cash Provided by (Used in) Operating Activities	$374,943	$455,200	$532,200	$492,600
Cash and Cash Equivalents, at Carrying Value	$403,815	$488,100	$529,800	$515,600
Restricted Cash, Current	$151	$1,400	$2,000	$2,300
Restricted Cash, Noncurrent	$403	$300	$400	$200
Payments to Acquire Property, Plant, and Equipment	$156,680	$165,600	$157,600	$139,500
Proceeds from Sale of Property, Plant, and Equipment	$211	$100	$100	$0
Proceeds from Divestiture of Businesses	$2,500	$0	$0	$0
Payments for Previous Acquisition	$0	$0	$218,500	$218,500
Payments to Acquire in Process Research and Development	—	$23,400	$0	$0
Payments to Acquire Investments	$689,041	$1,276,600	$669,300	$773,000
Proceeds from Sale of Debt Securities, Available-for-sale	$501,939	$1,106,000	$793,600	$619,900
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale	$361,279	$199,300	$62,000	$56,200
Net Cash Provided by (Used in) Investing Activities	$20,208	$-160,200	$-189,700	$-237,100
Repayments of Long-term Debt	$467	$400	$500	$500
Payments of Debt Issuance Costs	—	$600	$0	$0
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	$18,484	$19,200	$15,800	$15,800
Payment, Tax Withholding, Share-based Payment Arrangement	$14,936	$3,400	$3,000	$3,000
Payments for Repurchase of Common Stock	$428,728	$203,600	$295,500	$132,700
Payment for Contingent Consideration Liability, Financing Activities	$0	$30,000	$0	$0
Net Cash Provided by (Used in) Financing Activities	$-425,647	$-218,800	$-283,200	$-120,800

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("BIO","financials")

Full statements spill as a table. For one cell: =jivedata("BIO","Revenue") or =jivedata("BIO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.